Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Lol!!! I think so...or it's the BIG SHORT crew still digging. BP will set everything straight. Imo
B-OM - 22 percent of patients had severe OM
Placebo - 70 percent of patients had severe OM
Awesome results. Looks like the anti-inflammatory properties in B are working!!!!!
Amen! CTIX will prevail. No one----not AF, not Mako, not Trump can stop science and the value/tag CTIX drugs will deliver!
All first in class and extremely valuable. The smartest thing Leo and Co can do is entertain as many BPs as possible and create good relationships. Soon enough there will be a pivotal data set released that will create the bidding war and FORCE one to jump over the other and move fast to get one of our drugs.
What will be that dataset?
Midwest north. Let's go CTIX!!!!! B-OM news could be the week
The is true. Very true.
A convoy of Pfizer reps walk into CTIX. Hmmmm. Why? I think...personally they wanted t check in on makos article. Lol. Hahaha
I snap their necks. Legit. I taught my daughter how to last week. I'm a simple man with exception of ihub. I live a simple life and harvest my own food... Heat my own house and stay off the grid. When the time comes hound. You can bring your family to my compound. We have enough.
And hopefully....when we all need it......BRILACIDIN and kevetrin will be available.
Bunny what happened to this kind of excitement?
____________________________________________
TheBunny Monday, 11/05/12 08:51:14 AM
Re: NotRichYet2 post# 10542
Post #
10545
of 176230 Go
>>HOW CAN A STOCK WITH A CURE FOR 50% of all cancers be selling at 92 cents ?<<
I know this questions is directed to Bioman but my take; If it wasn't for all the micro scammers in the last few years promising that they got the cure for the world, then just diluting their stockholders to near zero so a few insiders can 'Live Large', we would normally be about $3.50 range at this stage with all things considered.
Also the clobbering in 2008 got many to shun away as many unloaded at the bottom never to come back.
Investors been stung on so many of these 'Cure-all's that are 'just around the corner'. I have been. Ask any veteran mini-bio investor.
CTIX is so different and such a pleasure and welcome change to the others out there. Here we have a CEO that answer questions and gives as many details as he can to his stockholders. Other places when for months stockholders ask management 'Where is TOX?', it just goes unanswered.
I do believe we will see a healthy adjustment in share price when dosing PR is released and more so when results are published.
Investors want to see a bit more now-a-days before dipping in.
However they will miss the rapid growth if test results are outstanding but that's the trade off. As I have said before; Investor nature in some is such that they are more willing to buy something at $4.00 as that number seems to have 'value' and it's 'growing', rather than take the same set of circumstances in a pipeline and it's a $1.00, well hey, there not much value there...'hovering too close to the ground'. Lot of it is psychological. Topic for another day.
Watch how many start coming on here when we are over $2.00. Then when we get uplisted.
But now, the great unwashed feeling a bit unsure about Uncle Billy's recommendation will ask their broker for their opinion. What do you think the broker will say when they know zip about CTIX, and they would prefer to sell them something where he gets a extra 'back-door' commish ?
-bunny-
_______________________________________________________
In late 2012 CTIX had about 93 Million OS - and was just about to dose the first patient in the K phase 1 trial.
So no active trials yet. Here is the PR for the first patient being recruited and enrolled about - 3 days after your post above.
http://www.cellceutix.com/press-release/2016/11/17/cellceutix-hits-major-milestone-in-company-history-dosing-underway-for-new-cancer-drug-at-leading-hospitals
http://www.cellceutix.com/press-release/2016/11/17/first-patients-recruited-and-enrolled-in-cellceutix-clinical-trial-of-novel-anti-cancer-drug-kevetrin
_______________________________________
You were so excited about Leo and CTIX and they did not even have one HUMAN clinical trial dosing??? They only had a dream of Prurisol and were just about start dosing K. So now look at your attitude. I can actually see when you turned looking back - post by post.
So you were screaming this should have been in the 3.50 range back then with zero human clinical results and only 2 drugs on the pipeline....
Fast forward 4-5 years and we added Brilacidin and completed SEVERAL major HUMAN clinical trials with STELLAR results and you are now screaming this should be .60? Hmmmmmmmmmmmmmmmmmm?
And better yet - CTIX did all of this with only diluting 30 million shares? That is 30 million shares to buy a potential multi-billion or multi-blockbuster compound (B) and the entire platform, took K through a multi year successful phase 1, started a phase 2 Ovarian trial, completed a couple Prurisol trials and currently in a 2B showing much promise, have B Absssi phase 3 chilling with dominant data comparing it to Dapto from CTIX's phase 2B, OM phase 2 about to deliver interim results, PoC phase 2 UP/UPS onto the final cohort with excellent data thus far, and the list goes on......
So if 3.50 was your price back in late 2012 with zero clinical trials to boot and only P and K! What do you really value CTIX at now?
TIA
Daub
Bingo. I would like to know who is using PUMA. That is our problem child. Currently 1000x1000 bid ask sitting.
No one including me on this board has a real idea when or what will happen next. All opinions. But I do agree this is just traders The Aruda and Aspire numbers are not dilutive enough to have an effect to tank this.
Science moves forward each day. Good luck trading. I'll always wish good luck to open posters on real intentions. There are very few on ihub.
Let's hope for positive OM news Monday.
Go away. You were screaming how much a scam tx?d was just like this and it ran from trips to .009 in 2 days. Seriously take your meds man. They have been preloading for months and this will run like it has in the past. Riss sucks and we all know that. Hopefully the Purdue professor can bring technology and patents to the table on grow tech or oil extraction methods.
Let's run back to .00's or higher.
Brilacidin. ABSSSI - In February 2016, Cellceutix submitted a Special Protocol Assessment (SPA) request, along with a final protocol, to the FDA, for a Phase 3 clinical trial of Brilacidin for the treatment of Acute Bacterial Skin and Skin Structure Infection (ABSSSI) caused by Gram-positive bacteria, including methicillin-resistant Staphylococcus aureus (MRSA). We received from the FDA comments and considerations for incorporation into our study design. Management has decided to delay its response to FDA due to the low price per share of our common stock and the approximately $30 million costs required for this study which would result in significant dilution to our shareholders. Our strategy for now is to achieve success with other trials and attract partnering opportunities with significant down payments and milestone payments which can fund these trials.
LATEST 10Q
So I think they gave up the SPA talk for a bit. But I do think that the company may take a full buyout. Just a whisper. They may be aligning all of these PoC and mid phase 2 trials to show BP exactly what htey want with a guaranteed phase 3 new antibiotic sitting there and if K proves out better than expected with a good update on oral ------ we may see a huge buyout. Upwards of 17 billion outright. JMO
Long until Leo sells - CTIX
Puma/CDEL always bring it down with zero consideration.
Have not read the board today so I will check it out. Thanks!!!
That trial began in mid 2015. Very excited
Feb 16th PR stated OM results in approx 6-8 weeks. Next week is 6 weeks!!!!!
Thank you for that. I agree. Big money will come
These results for UP are making a strong case for OM's success. Very encouraging data today.
It is interesting to see PUMA move it's ASK of 100 up 1 cent constantly
Good buying. Almost at 300K volume
The more eyes the better...thx! But if you ever speak to CTIX...you will find them to be very confident. They know the writing on the wall.
As EARLY as 2-3 weeks we will have B-OM data. Next week more positive data from first 2 cohorts of B-UP.
The doors are being knocked at ctix hq daily.
Have a great weekend all.
;). It's valuable. Maybe not today....but......in the future it should add a couple hundred million to market cap
FDA granted Rare Pediatric Disease Designation to Kevetrin for the treatment of retinoblastoma. This voucher awarded to CTIX is extremely valuable. For example, United Therapeutics sold its voucher to Abbvie for 350 MILLION dollars.
So once K is approved for Ovarian it won't be long for this indication and boom!!!! You can add that value to CTIX on top
BLANK indication for K received the BLANK Designation that recently was sold last year by BLANK company to another BP for $BLANK ...
Just testing you. And honestly losing my mind ready this board......Please fill in the BLANKS
Great perspective.
Target: 2-4 weeks for B-OM interim results. There are currently zero approved drugs to prevent.
Fast Track status
Almost 2 years underway on this trial.
Very exciting g times.
No Amatuer. It's BP saying hey Leo - "PLEASE SHOW ME X, Y and Z in human clinical trials and our unlimited piggy bank is all yours". CTIX is doing exactly what our future partner wants. And we are not failing. That is the most ignored piece of info here. They have made it clear as day to us. Sit back and relax while these trials produce the data this summer and I will guarantee we have either a buyout of one of the drugs or a first partner. IMO.
Go thru all PRs and interviews and presentations. It's clear as day CTIX is moving down he path to MAXIMIZE shareholder value, not just settle.
Watch and learn
Their canalytix. Website was updated.
Looks like some new products and services are coming. Possibly ticker move or name change.
Isn't that in April?
You're not offending anyone. And your right but also wrong. CTIX is on OTC and therefore the "intelligent" and big money horses are not in this race. We have traders and tiny people investing here. Most of these investors could not spell P-53. All we have is SA writers screaming the CTIX offices are empty and posters that I don't need to mention yelling Leo needs to buy shares. I mean right there you can see what is going on and who CTIX current audience is.
Just a friendly reminder. When a new name like Dr B joins a company as President, I would assume we will see a first partner within a year or a little longer. It's a proven track record for small pink sheet companies that do so. Things take time and Dr B is lining up these trials to show highest potential value of each product to get the highest return on each compound. ATLEAST for the capital that CTIX currently has.
First partner will equate to higher exchange and real coverage. Real firms that cover CTIX will put a much more accurate valuation next to its name. It's just a waiting game for B-OM , B-UP, P and K. All due this year.
"The past few months laid the groundwork for some fast-approaching milestones that represent pivotal moments for Cellceutix. As mentioned by management in previous news releases, a primary focus for the 2017 calendar year is completing work necessary to forge partnerships with larger pharmaceutical companies presently engaged with Cellceutix, some under Confidential Disclosure Agreements (CDAs)."
Light speed! Tracks of a bunny will always be found
Depending on data...the bidding may take a "crazy" turn for the best. Hopefully more interest and meetings are had in the next months...making the early birds a little less confident in their price offer. Up up and a way.
Data is all that awaits us. Deal is done...just need to see HOW MUCH!!!! Based off data. Mgmt do not need to retire shares or buy more. Deal is done. Must a Sunday stroll waiting game.
Why do I feel the FUD has permanently brought real expectations to their knees? Like I just posted...there is not one scientific blurp to date to give any low ball estimates a valid argument. IMO.
Watch K reduce tumor size in a 3 week trial. Big reductions. The scientific community will know Kevetrin in 2017.
CTIX has 3 potential MEGA blockbuster first in class drug candidates. Each forever never experiencing a negative outcome through several years of human clinical trials ---- I think 8 or 9? Plus previous Poly tests.
This fact keeps our odds on the friendly side for someday tendering an offer for 10's of billions from a partner or buyout.
I think K could be worth 25 billion alone. Just look at all the cancers P53 has its legs around.
https://static01.nyt.com/images/2016/05/15/magazine/15oncologist3/15oncologist3-superJumbo-v4.jpg
Me too. Not normal. IMO.
I'm all about it. And super excited for this K phase 2 to render data. If once a week K at low doses make pAtients feel better..hell it even made a tumor disappear. Now we see it at 250mg 3xs a week.
Let's see some cohort B data tomorrow. For Up. I expect full response for all 6 patients.
Over 6.30 fully diluted per billion.
This IMO is well over 2 billion today. You have a phase 3 lock in b Absssi.
This drug has several real life benefits OVER Dapto and Dapto is a blockbuster.
Throw K and P and all the other B indications out the door...I think you get well over 2-3 billion today for B-Absssi.
I'm sick of all this negative BS here. This is real life not some traders paradise or some shady short island. The drugs that CTIX have developed are all first in class and are part of multi billion dollar indications. CTIX has not failed one trial and I don't foresee any current trial failing based on earlier studies/pre-clinical work and having Dr M behind them.
So as the data comes in it will prove the value. Again. It's real life and BP has a need to fill pipelines. CTIX should continue to hold tight and stay the course. Let the data bring the bids. Up the ante.
I whole heartedly believe 25 billion is a starting bid price FOR CTIX when B K and P are all successful.
Can we compare that number to PUMA MM? It would be interesting.
That is a great story. Partnership news after hours would crush many.